24 Roy Street, #437
Seattle, WA 98109
Complete this contact form for media, investor relations and partnership/business development inquiries
Please leave this field empty.
* required fields
A Feasibility Study of the Nativis Voyager System in Patients with Recurrent Glioblastoma Multiforme (rGBM). This study is closed and NOT recruiting any furhter patients.
Abstract presented by Xavier Figueroa, PhD, at Society for Neuro-Oncology 2016 Annual Conference, Scottsdale, AZ on November 19, 2016.
The latest information on publications highlighting Nativis research and advancements.
May 30, 2017
Nativis Publishes Proof of Concept Paper Using Voyager™ System to Inhibit Enzyme in Algae
May 26, 2017
Non-Thermal Radio Frequency Stimulation Inhibits the Tryptophan Synthase Beta Subunit in the Algae Chlamydomonas reinhardtii
Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization In Vitro: A Potential Therapy For Cancer Treatment
Nativis Voyager® ulRFE™ System for rGBM is an investigational medical device. Limited by Federal (or United States) law to investigational use only.
© Nativis 2015 - 2017